VP, Mergers & Acquisitions

Iterative Health • Cambridge, MA

4d • Hybrid

About The Position

The Vice President, M&A at Iterative Health will lead the evaluation, structuring, negotiation, and execution of strategic acquisitions and other inorganic growth opportunities. Partnering closely with the Chief Development Officer, executive leadership, and cross-functional teams, this leader will own the end-to-end transaction lifecycle, from market mapping and partial target sourcing through due diligence, closing, and post-acquisition integration. This individual will also help establish a disciplined, scalable M&A function that supports the company's long-term strategic and financial objectives, including opportunities to expand our clinical research site network through acquisitions and de novo development.

Requirements

• Deep M&A expertise with strong healthcare/health-tech experience, executive presence, analytical rigor, and exceptional transaction execution skills.
• 8-10+ years of relevant experience in M&A, corporate development, investment banking, private equity, or a combination of these disciplines, preferably with experience in healthcare services, life sciences or an adjacent multi-site industry.
• Significant experience leading and closing complex acquisitions and strategic transactions.
• Demonstrated experience managing transactions across the full M&A lifecycle, from sourcing through integration.
• Strong understanding of healthcare, health-tech, life sciences, digital health, healthcare technology, or adjacent markets.
• Deep knowledge of physician practice management and financial management of physician practices to include reimbursement systems, metrics and operational challenges.
• Exceptional financial modeling, valuation, transaction structuring, and analytical capabilities.
• Experience presenting transaction recommendations to C-suite executives and/or Boards of Directors.
• Strong negotiation skills and demonstrated ability to manage sophisticated external advisors and counterparties.
• Results-oriented individual, with the capacity to follow through on pragmatic plans and ensure alignment of interests through effective communication
• An engaging, visible, and persuasive individual who is highly capable of building trust and motivating colleagues. High-energy with enthusiasm for the company’s mission
• An individual who embodies Iterative Health’s values: growth, responsibility, impact, and team
• An individual whose honesty, integrity and presence inspire trust and enduring relationships
• Proven ability to operate effectively in a dynamic, high-growth, entrepreneurial environment.
• Bachelor's degree required

Nice To Haves

• MBA or other advanced degree preferred.

Responsibilities

• Partner with the Chief Development Officer, executive leadership and both internal and external stakeholders to lead the identification, evaluation, structuring, negotiation, and execution of acquisitions and other strategic transactions that advance Iterative Health's growth strategy.
• Develop and execute an M&A strategy aligned with company growth priorities and financial objectives.
• Identify, evaluate, and prioritize acquisition and de novo opportunities across clinical research, healthcare services, life sciences, and adjacent markets.
• Build a robust pipeline of acquisition targets through industry relationships, proprietary sourcing, investors, and external advisors.
• Conduct market mapping and competitive analysis to assess strategic fit, growth potential, and value creation opportunities.
• Lead the end-to-end M&A lifecycle, including valuation, financial modeling, due diligence, deal structuring, negotiation, and closing.
• Coordinate cross-functional diligence across finance, legal, operations, people, technology, and regulatory functions to identify risks and opportunities.
• Develop acquisition models, return analyses, pro forma projections, and assessments of synergies, capital requirements, and transaction economics.
• Partner with internal stakeholders and external advisors to structure transactions, negotiate terms, and manage documentation through close.
• Evaluate acquisition and de novo opportunities to expand Iterative Health's clinical research site network and geographic reach.
• Partner with business and functional leaders to assess operational feasibility, investment requirements, and opportunities for scalable growth.
• Lead post-acquisition integration planning and translate transaction assumptions into measurable operating priorities and value-creation initiatives.
• Monitor post-close performance and refine integration processes to maximize transaction value.
• Establish scalable M&A processes, evaluation frameworks, approval workflows, and pipeline reporting.
• Present acquisition opportunities, financial analyses, transaction updates, and recommendations to the Chief Development Officer, executive leadership, and Board of Directors, as appropriate.
• Build relationships with industry executives, investors, founders, and advisors to strengthen deal flow and market intelligence.
• Mentor and develop corporate development team members as the function scales.
• Performs related duties as requested

Benefits

• Hybrid work environment with in-office collaboration two days per week in either our NYC or Boston office
• Comprehensive medical, dental, and vision coverage, with up to 80% of premiums covered by Iterative Health
• Mental health and wellness support through Spring Health
• Health HSA or FSA options, and commuter FSA contributions supported by Iterative Health
• Unlimited PTO, 12 company holidays, and a company-wide shutdown between Christmas and New Years
• 401(k) program with a company match of up to 3% (up to $3,000 annually)
• Weekly in-office lunch benefit every Tuesday
• 100% company-paid short-term and long-term disability coverage
• Annual wellness and professional development stipend to support your health and growth

What This Job Offers

• Job Type: Full-time
• Career Level: Executive